Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 2,287,465 9.210% | 15,092![]() (+0.66%) | Filing History |
2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Bio-Rad Laboratories, Inc. BIO | FMR LLC | 1,928,323 7.764% | 236,069![]() (+13.95%) | Filing History |
2022-01-31 5:49 pm Sale | 2021-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,768,081 7.100% | -124,255![]() (-6.57%) | Filing History |
2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | The Vanguard Group | 2,272,373 9.180% | 294,846![]() (+14.91%) | Filing History |
2021-02-08 10:17 am Purchase | 2021-02-05 | 13G | Bio-Rad Laboratories, Inc. BIO | FMR LLC | 1,692,254 6.840% | 1,692,254![]() (New Position) | Filing History |
2021-01-28 5:56 pm Sale | 2020-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,892,336 7.600% | -426,716![]() (-18.40%) | Filing History |